Advertisement
News
Advertisement

The agreement enables Medutech to market ETView's VivaSightT airway management platform in Mexico.

Mon, 04/09/2012 - 2:45am
The Associated Press

TEL AVIV, Israel--(BUSINESS WIRE)--Apr 9, 2012-- ETView Medical, Ltd.

(TASE: ETVW) announced today that it has entered into a distribution agreement with Medutech Co., Ltd. (Medutech). The agreement enables Medutech to market ETView's VivaSight(TM) airway management platform (previously known as TVT(TM)), combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability, in Mexico for a period of 2 years. Other terms were not disclosed.

William Edelman, CEO of ETView Medical, commented, "We are excited to add Medutech to our expanding distributor network." Mr. Edelman continued, "VivaSight(TM) is currently being distributed across Europe, Asia and the United States. VivaSight(TM) provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation." On March 19, 2012, ETView announced a distribution agreement with Amphar b.v., a medical device and generic pharmaceutical distributor in the Netherlands.

On March 12, 2012, ETView announced KFDA Pre-Market Clearance for the VivaSight(TM)-SL line of Innovative Airway Devices.

On March 5, 2012 and February 6, 2012, ETView announced filing of a Technical File, initiating CE Registration and a Pre-Marketing Notification Application (510(k)) with the FDA for the Viva(TM) EB Line of Innovative Endobronchial Blockers. On December 12, 2011, ETView announced that the company filed a Pre-Marketing Notification Application (510(k)) with the FDA for the VivaSight(TM) DL Airway Management System. VivaSight(TM)-DL1 is a proprietary, single-use disposable medical device, consisting of a dual lumen airway ventilation tube with an integrated continuous high resolution video airway imaging system permitting airway control and lung isolation during certain surgical procedures.

On February 7, and February 2, 2012, ETView announced distribution agreements with NeuroMed Ltd. (NeuroMed), a surgical products sales and distribution company based in St. Petersburg, Russia, and State of the Art (SOTA) Medical Products, Inc., a specialty surgical products sales and distribution company, based in Cedar Grove, New Jersey.

About Medutech Ltd.

According to information provided to the company, Medutech S.A. DE C.V., Ltd., was founded in 2006. Medutech currently markets and distributes medical devices focused on airway management.

Headquartered in Mexico City, Medutech focuses on business development and regional country wide marketing via a network of clinical support staff and experienced sales executives. Medutech provides extensive in-hospital training for a variety of airway management products, including laryngoscopes, laryngeal masks and bronchoscopy.

About ETView Medical, Ltd.

ETView Medical, Ltd. (TASE: ETVW) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented VivaSight(TM)-SL, a single-use disposable medical device, consisting of a single lumen ventilation tube with an integrated continuous high resolution video imaging system is currently sold in Europe, Israel, and the US to overcome current limitations and associated adverse surgical events during lung isolation surgeries.2 It is estimated that over 1.9 million lung isolation procedures are conducted worldwide annually,3 accounting for over $250mm in single-use medical disposables.4 Forward-Looking Statement The Company estimations in this press release, including those estimations regarding the Company's predicted scope of business, constitute forward-looking statements, as such term is defined under the Israeli Securities Law (5728-1968), and there is no certainty that such estimations shall materialize. The Company's estimations are based on business assumptions, prior experience, and professional data. Due to various factors, foreseen and unforeseen, including, but not limited to, changes in market trends, competition, global or local economic conditions, and amendments of regulation, such estimations may not materialize in whole or in part, or materialize in a substantially different manner than anticipated by the Company.

1 Patent Pending 2Anesthesiology. 2006;105:471-477.

3National Health Statistics Reports Number 29, October 26, 2010 4Company estimates on file CONTACT: ETView Medical, Ltd.

Bill Edelman, CEO Worldwide: +1 567 248 4821 In Israel: +972 72 260 7060 bill.edelman@etview.com www.etview.com KEYWORD: UNITED STATES MEXICO NORTH AMERICA CENTRAL AMERICA NEW YORK MIDDLE EAST ISRAEL INDUSTRY KEYWORD: SURGERY HEALTH MEDICAL DEVICES SOURCE: ETView Medical, Ltd.

Copyright Business Wire 2012 PUB: 04/09/2012 06:00 AM/DISC: 04/09/2012 06:00 AM http://www.businesswire.com/news/home/20120409005418/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading